A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510541-25-00

Acronym

NX-5948-301

Enrollment

250

Registered

2024-03-07

Start date

2023-10-09

Completion date

Unknown

Last updated

2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed/Refractory B-cell Malignancies

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Italy, Netherlands, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026